Day's Trending USA Stocks | Indaptus Therapeutics Inc: Overnight Gain 46.8%, Surges Amid Short Squeeze, Thin Float, and Immunotherapy Platform Speculation
Indaptus Therapeutics Inc INDP | 0.00 | |
StablecoinX, Inc. Class A USDE | 0.00 | |
Canaan Inc. CAN | 0.00 | |
MARA Holdings MARA | 0.00 | |
Maravai Lifesciences Holdings, Inc. Class A MRVI | 0.00 |
Editor's Note: the "Trending USA Stocks" column tracks the day's top bullish stocks in the USA market, aiding investors in promptly identifying opportunities for potential gains.
20/08/2026 Eastern Time in USA The Dow Jones Industrial Average dropped by 1.32%, closing at 52759.21 points; the Nasdaq Composite dropped by 1.0%, closing at 26067.17 points; the S&P 500 Index dropped by 0.87%, closing at 7641.16 points. Sahm has compiled the Top 10 Daily Stock Price Gainers in the USA market.

Indaptus Therapeutics Inc: Overnight gain 46.8%, Surges Amid Short Squeeze, Thin Float, and Immunotherapy Platform Speculation
Indaptus Therapeutics, Inc. was incorporated in the State of Delaware on February 24, 2021, and is positioned as a clinical-stage biopharmaceutical company. The Company is focused on the development of systemic anti-tumor and antiviral immunotherapies derived from attenuated, inactivated Gram-negative bacteria. Its lead product candidate, Decoy20, was previously evaluated in a Phase I clinical trial enrolling patients with advanced solid tumors; however, further clinical development of the compound has since been discontinued.
Indaptus Therapeutics Inc (INDP) Surges 46.8% Overnight Amid Technical Rebound Shares of Indaptus Therapeutics Inc (INDP) posted a sharp overnight gain of 46.8%, though the stock remains down 52.6% year-to-date, with the rally occurring against a backdrop of prolonged and significant price deterioration. A comprehensive analysis suggests the advance was driven by three primary factors. First, following substantial selling pressure, the stock's depressed valuation triggered short-covering activity, prompting a technical mean-reversion rebound. Second, as an early-stage clinical-stage micro-cap biotechnology company, INDP's limited float and shallow market depth render the shares highly susceptible to outsized price swings driven by relatively modest capital flows. Third, speculative positioning may reflect market anticipation of potential strategic repositioning surrounding the company's immunotherapy platform based on attenuated, inactivated Gram-negative bacteria. Overall, the move is broadly characterized as a short-term technical recovery following an extended period of oversold conditions, rather than a fundamental re-rating.
StablecoinX Inc. Class A: Overnight gain 29.4%, Surges Amid Stablecoin Sector Rally, Infrastructure Expansion, and Technical Rebound
StablecoinX Inc. Class A Company Overview & Business Operations StablecoinX Inc. was incorporated in the State of Delaware on June 30, 2025, positioning itself as an infrastructure software and services company dedicated to supporting the Ethena ecosystem, including its digital dollar product, USDe. The Company's operations are organized across three principal business segments: Infrastructure Services, Infrastructure Software, and Distribution Services. To date, StablecoinX has commenced operations across two Infrastructure Services verticals. The first encompasses a full-stack validator node service, with the underlying intellectual property held pursuant to a perpetual, non-exclusive, royalty-free license. The second comprises a decentralized validator node service, through which the Company operates as a cross-chain validator within the Ethena ecosystem. Looking ahead, StablecoinX intends to develop a middleware API platform designed to facilitate enterprise-level integration of USDe and related digital asset products. In addition, through its Distribution Services segment, the Company plans to drive broader adoption of Ethena's digital dollar products among traditional financial institutions, asset managers, and investors, while generating fee-based revenue from such distribution activities. --- This disclosure is intended for informational purposes and reflects the Company's current business structure and strategic initiatives as of the date of incorporation.
StablecoinX Inc. Class A (USDE) Surges 29.4% on Multiple Converging Catalysts The sharp single-day rally in StablecoinX Inc. Class A (USDE) shares can be attributed to the convergence of several key factors. Renewed bullish sentiment across the stablecoin sector has driven concentrated capital inflows into USDE, bolstered by the company's deep integration with the Ethena ecosystem and its USDe stablecoin product. Expanding infrastructure business prospects — including validator services and decentralized validation node operations — have provided additional fundamental catalysts. Furthermore, following a steep year-to-date cumulative decline of approximately 57.5%, technical oversold conditions created strong mean-reversion buying pressure. Compounding these dynamics, the company's limited operating history and constrained float have resulted in a significant supply-demand imbalance, amplifying price volatility and contributing to the outsized 29.4% intraday gain. The rally reflects a multi-factor resonance of sector momentum, improving business outlook, technical recovery, and small-cap liquidity dynamics.
Canaan Inc.: Overnight gain 16.2%, Surges Amid Bitcoin Rally, Policy Tailwinds, and ADS Buyback Announcement
Canaan Inc. Incorporated in Cayman Islands, Establishes Leading Position in Global Bitcoin Mining Equipment Market Canaan Inc. (the "Company") was incorporated on February 6, 2018, under the laws of the Cayman Islands. The Company is principally engaged in providing cryptocurrency mining solutions powered by its proprietary Application-Specific Integrated Circuit ("ASIC") chips developed through in-house research and development. As one of the few fabless IC design companies worldwide with independent ASIC design capabilities, access to leading-edge wafer foundry capacity, and mass production capabilities for Bitcoin mining hardware, Canaan Inc. has established a prominent position in the global Bitcoin mining equipment market. Furthermore, leveraging its extensive technical expertise in ASIC chip design, the Company's operating subsidiaries have successfully launched edge computing chips based on the RISC-V architecture, specifically tailored for intelligent digital devices, marking a significant expansion of its semiconductor technology portfolio beyond its core cryptocurrency mining business.
Canaan Inc. (CAN) Surges on Confluence of Policy Tailwinds and Fundamental Catalysts. Shares of Canaan Inc. (CAN) rallied sharply, driven by a convergence of multiple positive catalysts. On the macro front, U.S. President Trump met with crypto industry executives at the White House, urging Congress to advance related legislation, while the SEC signaled potential exemptions for certain digital asset issuances from securities registration requirements. Concurrently, Bitcoin surpassed $70,000, reaching its highest level since June 2, lifting the broader crypto sector. On the fundamental side, Canaan mined 46 BTC in July, maintaining a stable Non-JV hash rate at 10.05 EH/s with an all-in power cost of just $0.043/kWh. The company's treasury holdings of 1,917 BTC and 3,952 ETH appreciated significantly alongside rising token prices. Additionally, management authorized monetization of digital assets to fund ADS buybacks, noting current market capitalization falls below combined digital asset and cash holdings — a signal that meaningfully bolstered investor confidence.
The Top 10 Daily Gainers in the USA market are listed as follows:
Company&Ticker | Cap$bn | Daily Change | YTD Change |
| Indaptus Therapeutics Inc(INDP.US) | 0.18 | 46.8% | -52.6% |
| StablecoinX Inc. Class A(USDE.US) | 0.11 | 29.4% | -57.5% |
| Canaan Inc.(CAN.US) | 0.21 | 16.2% | -59.6% |
| MARA Holdings(MARA.US) | 4.31 | 15.5% | 24.2% |
| Maravai Lifesciences Holdings, Inc. Class A(MRVI.US) | 2.15 | 14.8% | 155.1% |
| Bit Digital, Inc.(BTBT.US) | 0.57 | 13.9% | -15.6% |
| Prelude Therapeutics, Inc.(PRLD.US) | 0.52 | 12.5% | 124.1% |
| Iovance Biotherapeutics Inc(IOVA.US) | 4.07 | 12.5% | 229.3% |
| Andersen Group, Inc. Class A(ANDG.US) | 5.69 | 11.8% | 94.1% |
| Cantor Equity Partners(XXI.US) | 3.48 | 11.5% | -29.3% |
